Koyfin Home > Directory > Health Care > Aeglea Biothera > Cash from Investing Activities

Aeglea Biothera Cash from Investing Activities Chart (AGLE)

Aeglea Biothera annual/quarterly Cash from Investing Activities from 2014 to 2020.
  • Aeglea Biothera Cash from Investing Activities for the quarter ending June 06, 2020 was $-57m a 128.21% decrease of -73m year over year
  • Aeglea Biothera Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-16m a 9.40% decrease of -1m year over year
  • Aeglea Biothera Annual Cash from Investing Activities for 2019 was $-2m a -775.85% increase of 13m from 2018
  • Aeglea Biothera Annual Cash from Investing Activities for 2018 was $-15m a -47.92% increase of 7m from 2017
  • Aeglea Biothera Annual Cash from Investing Activities for 2017 was $-23m a 46.40% decrease of -10m from 2016
Other Cash Flow Metrics:
  • Aeglea Biothera Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -3.43% increase of 0m year over year
  • Aeglea Biothera Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-6m a 25.45% decrease of -2m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE Cash from Investing Activities Data

06/2020$-57m
03/2020$15m
12/2019$10m
09/2019$16m
06/2019$-42m
03/2019$14m
12/2018$-2m
09/2018$1m
06/2018$-19m
03/2018$5m

Annual AGLE Cash from Investing Activities Data

2019$-2m
2018$-15m
2017$-23m
2016$-12m
2015$-4m
2014$0m